Recent News & Upcoming Events

RECENT NEWS

March 31, 2010
Cerus Signs Agreement with Swiss Red Cross for Deployment of the INTERCEPT Blood System for Platelets

May 18, 2010
Whittemore Peterson Institute and Cerus Confirm Inactivation of XMRV by the INTERCEPT Blood System

June 30, 2010
Study Results Presented at International Transfusion Congress Highlight Cerus' Progress Toward Improving the Safety of Platelets, Plasma and Red Blood Cells

For more news, visit cerus.com's investor site arrow

RECENT WEBCASTS

June 30, 2010 | ISBT Symposium
A Pragmatic Approach to Pathogen Inactivation Decisions
Experiences of Recent Adopters of the INTERCEPT Technology
> View webcast

February 17 - 19, 2010 | International Hemovigilance Seminar (IHS), Dubrovnik, Croatia
Active Hemovigilance Results for INTERCEPT - Review of Multi-Year Studies Presentated at International Hemovigilance Seminar (IHS)
> View webcast

January 2010
Current Status of RBC Component Viability Requirements
> View webcast

October 27, 2009 | AABB Workshop
Establishing the Safety and Efficacy of Pathogen Inactivation
The role of powered clinical studies for medical device development in transfusion medicine
> View webcast

UPCOMING EVENTS

September 1 - 2, 2010
Kvalitetssikring Transfusjonstjenesten
Oslo, Norway

September 2 - 4, 2010
Joint Congress of European Society for Haemapheresis and Haemotherapy (ESFH) with the World Apheresis Association (WAA), Blood Transfusion Service of the Swiss Red Cross (BTS/SRC) and Swiss Association of Transfusion Medicine (SATM)
Interlaken, Switzerland
Additional Information >

September 6 - 7, 2010
Congress on Bleeding and Transfusion (ISCB)
Copenhagen, Denmark
Additional Information >

September 7 - 8, 2010
1st International Workshop on XMRV
Bethesda, Maryland, USA
Additional Information >

September 9 - 11, 2010
British Blood Transfusion Society (BBTS) 28th Annual Conference
Bournemouth, UK
Additional Information >

September 21 - 22, 2010
LINKÖPINGSDAGARNA
Linköping, Sweden
Additional Information >

October 9 - 12, 2010
AABB Annual Meeting & CCTXPO 2010

Baltimore, Maryland
Additional Information >

Breakfast Workshop

"Making blood safety decisions in the face of uncertainty: Considering the potential role of pathogen inactivation as protection against XMRV and future emerging agents"

7am Tuesday October 12, 2010
Baltimore Conference Center - Room 337/338

October 14 - 15, 2010
Regional blodbankkonferanse
Bodoe, Norway

October 21 - 24, 2010
Société Française de Transfusion Sanguine (SFTS) / Euro'Sat
Beaune, Burgundy, France
Additional Information >

October 28 - 30, 2010
XXVI Congreso Nacional de la SETH & LII Reunion Nacional de la AEHH
Las Palmas de Gran Canaria
Additional Information >

November 19, 2010
Société Française d'Hématologie (SFH) Congreès 2010
Marseille, France
Additional Information >

December 8 - 10, 2010
IXème Congrès National d'Hémovigilance et de Sécurité Transfusionnelle de le Société Française de Vigilance et de Thérapeutique Transfusionnelle
Reims, France
Additional Information >

December 4 - 7, 2010
American Society of Hematology (ASH)
Orlando, Florida, USA
Additional Information >

 

© Cerus Corporation. All Rights Reserved.

Use of the INTERCEPT Blood System in the United States is limited by Federal law to investigational use. If you are a resident of the U.S., please click here.

The information on this site is not country-specific, and may contain information that is outside the approved indications for the country in which you are located. The INTERCEPT Blood System is CE marked for use with platelets and plasma. No pathogen inactivation system has been shown to inactivate all pathogens.

Website design by NetPilot Web Solutions
Legal Info  |   Privacy Policy